Loading...
Grapefruit USA, Inc.
GPFT•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$0.002
$0.00(13.10%)
Grapefruit USA, Inc. (GPFT) Financial Performance & Income Statement Overview
Review Grapefruit USA, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-100.00%
↓ 100.00%
Operating Income Growth
71.92%
↑ 71.92%
Net Income Growth
34.17%
↑ 34.17%
Operating Cash Flow Growth
-90.05%
↓ 90.05%
Operating Margin
0.00%
Gross Margin
0.00%
Net Profit Margin
0.00%
ROE
15.93%
↑ 15.93%
ROIC
3.21%
↑ 3.21%
Grapefruit USA, Inc. (GPFT) Income Statement & Financial Overview
Review Grapefruit USA, Inc.'s (GPFT) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $8880.00 | $7897.00 | $353.00 | $3982.00 |
| Gross Profit | -$8880.00 | -$7897.00 | -$353.00 | -$3982.00 |
| Gross Profit Ratio | ||||
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $53549.00 | $53560.00 | $54285.00 | $77472.00 |
| Operating Expenses | $53549.00 | $53560.00 | $54285.00 | $77472.00 |
| Total Costs & Expenses | -$62429.00 | -$61457.00 | $54638.00 | $81454.00 |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $270082.00 | $234706.00 | $231160.00 | $229761.00 |
| Depreciation & Amortization | $0.00 | $0.00 | $4832.00 | $624.00 |
| EBITDA | -$62429.00 | -$61456.00 | -$49808.00 | -$80830.00 |
| EBITDA Ratio | ||||
| Operating Income | -$62429.00 | -$61457.00 | -$54640.00 | -$81450.00 |
| Operating Income Ratio | ||||
| Other Income/Expenses (Net) | -$267082.00 | -$234706.00 | -$226325.00 | -$229765.00 |
| Income Before Tax | -$329511.00 | -$296163.00 | -$280965.00 | -$311215.00 |
| Income Before Tax Ratio | ||||
| Income Tax Expense | $0.00 | $0.00 | -$280965.00 | -$4.00 |
| Net Income | -$329511.00 | -$296163.00 | -$280965.00 | -$311215.00 |
| Net Income Ratio | ||||
| EPS | -$0.00 | -$0.00 | -$0.00 | -$0.00 |
| Diluted EPS | -$0.00 | -$0.00 | -$0.00 | -$0.00 |
| Weighted Avg Shares Outstanding | $1.11B | $1.11B | $1.11B | $1.11B |
| Weighted Avg Shares Outstanding (Diluted) | $1.11B | $1.11B | $1.11B | $1.11B |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan